| MACEs group (n = 55) | Non-MACEs group (n = 95) | P value | Total (n = 150) |
---|---|---|---|---|
Age | 62.5 ± 9.6 | 63.8 ± 9.3 | 0.840 | 63.3 ± 9.8 |
Female (%) | 49 (89.1) | 72 (75.8) | 0.513 | 121 (80.7) |
BMI (kg/m2) | 25.0 ± 3.0 | 24.9 ± 2.8 | 0.920 | 25.1 ± 2.9 |
Cardiovascular risk factors | ||||
 Hypertension (%) | 45 (81.8) | 79 (83.2) | 0.513 | 124 (82.7) |
 Diabetes (%) | 39 (70.9) | 63 (66.3) | 0.048 | 102 (68) |
 History of smoking (%) | 32 (58.2) | 41 (43.2) | 0.344 | 73 (48.7) |
 HCY(umol/L) | 15.8 ± 9.8 | 15.3 ± 8.9 | 0.569 | 19.1 ± 10.3 |
 HGB (g/L) | 148.1 ± 19.7 | 149.6 ± 15.1 | 0.863 | 148.57 ± 18.4 |
 Scr (umol/L) | 69.1 ± 11.4 | 71.0 ± 12.1 | 0.915 | 70.9 ± 11.6 |
 TG (mmol/L) | 1.47 ± 0.44 | 1.24 ± 0.28 | 0.001 | 1.36 ± 0.36 |
 TCH (mmol/L) | 4.7 ± 1.0 | 4.6 ± 1.1 |  | 4.6 ± 0.9 |
 HDL-C (mmol/L) | 1.1 ± 0.2 | 1.2 ± 0.3 | 0.468 | 1.1 ± 0.3 |
 LDL-C (mmol/L) | 3.1 ± 0.9 | 3.0 ± 1.0 | 0.203 | 2.9 ± 1.0 |
 ApoA1 (g/L) | 1.1 ± 0.2 | 1.2 ± 0.1 | 0.055 | 1.15 ± 0.2 |
 ApoB (g/L) | 1.0 ± 0.2 | 1.0 ± 0.3 | 1.339 | 0.96 ± 0.3 |
CT-FFR | Â | Â | 0.038 | Â |
 CT-FFR ≤ 0.8 | 46 (83.6) | 58 (61.1) |  | 104 (69.3) |
 CT-FFR > 0.8 | 9 (16.4) | 37 (38.9) |  | 46 (30.7) |
 CDI (× 10–3/mmHg) | 3.5 ± 0.6 | 4.0 ± 0.7 | 0.003 | 3.8 ± 0.7 |
MACEs (n = 55) | ||||
 Death |  |  |  | 3 (5.5) |
 Angina |  |  |  | 11 (20) |
 Cardiac failure |  |  |  | 2 (3.6) |
 PCI |  |  |  | 34 (61.8) |
 CABG |  |  |  | 5 (9) |